Expertise in delivering first class preclinical translational research

We are a leading Contract Research Organisation providing high quality electrophysiological services to the Pharmaceutical & Biotechnology industry.

Publications
Posters

Team

Professor David Spanswick

Cofounder

David has over 30 years of experience in electrophysiology and neuroscience. He graduated from the University of East Anglia, UK in 1986 (B.Sc). He then obtained his PhD at University of Birmingham, studying neurophysiology.

Prior to establishment of NeuroSolutions, Prof. Spanswick acted as a consultant to a number of multinational pharmaceutical companies.

Prof. Spanswick is the author of over 50 academic publications in his area of expertise. In addition to his role as Chief Scientific Officer with NeuroSolutions Ltd, Dave was appointed a senior lecturer, University of Warwick in 2000 and Professor of Molecular Neuroscience at Warwick Medical School in 2004. In 2011 Dave joined the Department of Physiology at Monash University.

Dr Fei-Yue Zhao

Cofounder

Dr Zhao is a co-founder of NeuroSolutions and has been Technical Officer since establishment. Dr Zhao is an internationally recognised expert in pain research, having worked previously in laboratories in the UK and Japan.

Dr Zhao has over 30 years’ experience in system electrophysiology and had worked in multiple drug discovery programs in the pain area since 1999. Prior to joining NeuroSolutions, Dr Zhao was head of system electrophysiology at Parke Davis/Pfizer in Cambridge, UK where he worked on the site and mechanism of action of Gabapentin.

 

"Thank you for the absolutely phenomenal work you have done for Redpin. As biotech managers, we frequently push CROs to the max and sometimes take them for granted. After reviewing the work that you have done over the past year, I felt that I needed to let you know what a difference you had made to Redpin’s growth and success. Your work has been of the highest caliber and your dedication unmatched."

Elma Hawkins PhD, MBA, former President and CEO Redpin Therapeutics, Inc.

"I have worked with NeuroSolutions on many projects over many years. The quality of the data is second to none, their scientific expertise and collaborative approach to our technicality demanding projects has been excellent. For example, the work on SEN1576 has led to high-impact joint publications with Senexis and this compound is now being developed by Talisman Therapeutics.."

Dr Mark Treherne - As former Chief Executive of Senexis Limited (Dr Treherne is currently Chief Executive of Life Sciences Organisation at UK Trade & Investment, which helps UK business trade overseas).

In partnership with
Science Exchange
Pacific Discovery Services
scientist.com
NeuroSolutions Ltd

Email: info@nsolns.com
Contact Head-office on +44 (0) 8454 500171


One of our partner companies may be better suited to your requirements

AUSTRALASIA
Pacific Discovery Services

Email: info@pacificdiscoveryservices.com